BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 2217209)

  • 41. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.
    Tennant RW; French JE; Spalding JW
    Environ Health Perspect; 1995 Oct; 103(10):942-50. PubMed ID: 8529591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity.
    Ennever FK; Lave LB
    Regul Toxicol Pharmacol; 2003 Aug; 38(1):52-7. PubMed ID: 12878054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.
    Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA
    Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutagenesis and carcinogenesis: endogenous and exogenous factors.
    Ames BN
    Environ Mol Mutagen; 1989; 14 Suppl 16():66-77. PubMed ID: 2659334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
    Ashby J
    Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interspecies extrapolation in carcinogenesis: prediction between rats and mice.
    Gold LS; Bernstein L; Magaw R; Slone TH
    Environ Health Perspect; 1989 May; 81():211-9. PubMed ID: 2759059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 49. Prediction of rodent carcinogenicity for 30 chemicals.
    Ashby J
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1101-4. PubMed ID: 8933060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The causes and prevention of cancer: gaining perspective.
    Ames BN; Gold LS
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):865-73. PubMed ID: 9255573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental design constraints on carcinogenic potency estimates.
    Rieth JP; Starr TB
    J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database.
    Gold LS; Slone TH; Bernstein L
    Environ Health Perspect; 1989 Feb; 79():259-72. PubMed ID: 2707207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hazard identification, classification, and risk assessment of carcinogens: too much or too little? - Report of an ECETOC workshop.
    Felter SP; Boobis AR; Botham PA; Brousse A; Greim H; Hollnagel HM; Sauer UG
    Crit Rev Toxicol; 2020 Jan; 50(1):72-95. PubMed ID: 32133908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Types and amounts of carcinogens as potential human cancer hazards.
    Weisburger JH; Williams GM
    Cell Biol Toxicol; 1989 Dec; 5(4):377-91. PubMed ID: 2627674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern.
    Kirkland D; Fowler P
    Mutagenesis; 2010 Nov; 25(6):539-53. PubMed ID: 20720197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expectations for transgenic rodent cancer bioassay models.
    Ashby J
    Toxicol Pathol; 2001; 29 Suppl():177-82. PubMed ID: 11695555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention versus chemophobia: a defence of rodent carcinogenicity tests.
    Infante PF
    Lancet; 1991 Mar; 337(8740):538-40. PubMed ID: 1671901
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment.
    Croy RG
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):289-302. PubMed ID: 8013422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.